These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11367188)

  • 81. Revised physician labelling for neuroleptic drugs: Food and Drug Administration. Notice.
    Fed Regist; 1980 Aug; 45(155):52931-3. PubMed ID: 10314517
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
    Shulman LP; Bateman LH; Creinin MD; Cullins VE; Doyle LL; Godfrey E; Murphy P; Rodriguez P; Spear SJ; Stewart FH; Thomas MA; Westhoff CL; Worthington S
    Contraception; 2006 May; 73(5):440-2. PubMed ID: 16627028
    [No Abstract]   [Full Text] [Related]  

  • 83. FDA to require pediatric studies for drugs commonly used in children.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):203. PubMed ID: 10030499
    [No Abstract]   [Full Text] [Related]  

  • 84. FDA reevaluating labeling policy for dually classified drugs.
    Raef TA
    J Am Vet Med Assoc; 1990 Jun; 196(11):1743-4. PubMed ID: 2351590
    [No Abstract]   [Full Text] [Related]  

  • 85. Impact of regulations on artificial organs research.
    Morton WA; DeVries WC; Dobelle WH; Serkes KD; Sheridan R; Dennis C
    Trans Am Soc Artif Intern Organs; 1983; 29():770-3. PubMed ID: 6673323
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Workshop on conflicting guidelines for the use of vaccines.
    Halsey NA; Hall CB
    Pediatrics; 1995 Jun; 95(6):938-41. PubMed ID: 7761228
    [No Abstract]   [Full Text] [Related]  

  • 87. FDA chief says demand by patients for more drug information is genuine.
    Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629
    [No Abstract]   [Full Text] [Related]  

  • 88. Name that drug ... a game with the FDA.
    J Am Optom Assoc; 1998 Feb; 69(2):75, 133. PubMed ID: 9549256
    [No Abstract]   [Full Text] [Related]  

  • 89. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?
    Kaunitz AM
    Hosp Med Staff; 1982 Feb; 11(2):15-8. PubMed ID: 10254209
    [No Abstract]   [Full Text] [Related]  

  • 91. New FDA policy encourages inclusion of women in clinical trials.
    Clin Pharm; 1993 Oct; 12(10):712-3. PubMed ID: 8258252
    [No Abstract]   [Full Text] [Related]  

  • 92. PCM-4, OTC hopeful?
    Servilio J
    Posit Aware; 1995; ():7. PubMed ID: 11362672
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Declaring the sodium content of drug products.
    Szarfman A; Kuchenberg T; Soreth J; Lajmanovich S
    N Engl J Med; 1995 Nov; 333(19):1291. PubMed ID: 7566018
    [No Abstract]   [Full Text] [Related]  

  • 94. Estrogen PPIs. An FDA survey.
    Morris LA; Myers A; Gibbs P; Lao C
    Am Pharm; 1980 Jun; NS20(6):22-6. PubMed ID: 7395715
    [No Abstract]   [Full Text] [Related]  

  • 95. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1999 Apr; 281(13):1164. PubMed ID: 10199413
    [No Abstract]   [Full Text] [Related]  

  • 96. The FDA "reinvents" human cell and tissue regulations.
    Brower V
    Nat Biotechnol; 1997 May; 15(5):411. PubMed ID: 9131612
    [No Abstract]   [Full Text] [Related]  

  • 97. Free enterprise and the FDA (a study in static mobility).
    Rev Allergy; 1968 Oct; 22(10):946-7. PubMed ID: 5761534
    [No Abstract]   [Full Text] [Related]  

  • 98. FDA calls for warnings on anaemia drugs amid reports of incentives to doctors.
    Tanne JH
    BMJ; 2007 May; 334(7602):1022. PubMed ID: 17510121
    [No Abstract]   [Full Text] [Related]  

  • 99. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Nov; 278(17):1394. PubMed ID: 9355985
    [No Abstract]   [Full Text] [Related]  

  • 100. FDA rules force hospitals to stop reusing, raise costs.
    DeJohn P
    Hosp Mater Manage; 2000 Dec; 25(12):1, 9-10. PubMed ID: 11142002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.